BNB Strategy: Windtree Therapeutics Targets New $520 Million Fund To Boost Holdings
Windtree Therapeutics (WINT), a biotech firm listed on Nasdaq, has recently made headlines by venturing into the cryptocurrency space, particularly focusing on Binance Coin (BNB). Just over a week after raising $60 million, the company announced a substantial partnership with Build and Build Corporation, unveiling a $200 million securities purchase agreement aimed at establishing a…
